VRUS Financial Facts
Net loss per share: basic and diluted: -0.6Research and development: 18.92M
See Full Income Statement
Prepaid expenses and other current assets: 3.53M
Amounts due from collaboration partner: 0
See Full Balance Sheet
Pharmasset (VRUS) Earnings
|
Expand Research on VRUS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -28.8% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/25/11 | Q211 | -$0.60 | -$0.58 | -$0.02 | N/A | $3.35M | N/A |  | | Details | |
| 4/25/11 | Q211 | -$0.55 | -$0.65 | +$0.10 | $247K | $440K | N/A | | | Details | |
| 2/7/11 | Q111 | -$0.69 | -$0.57 | -$0.12 | $200K | $600K | N/A | | | Details |
